Stock News

Cassava Looks to Extend Breakneck Rally on Alzheimer’s Data
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients
Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
Biogen and Eisai Announce ADUHELM™ (aducanumab-avwa) Data Presentations at Alzheimer’s Association International Conference 2021
Could These 3 Potential Blockbusters Transform Biogen?
Biogen to Present Data from ADUHELM and Alzheimer’s Disease Portfolio at 2021 Alzheimer’s Association International Conference
Biogen beats on earnings, says it's brought in $2 million in sales of Alzheimer's drug
AT&T, Crocs, Biogen top Q2 estimates, Didi shares dip as China regulatory woes persist
Biogen's Q2 Profit Falls 70% As Tecfidera Competition Hits Topline
UPDATE 2-Biogen defends Alzheimer's drug approval, reports $2 mln in early sales
Biogen says uptake on new Alzheimer's drug slower than expected

As seen on...